To assess the correlation between the levels of pY580-SHP2 and pY54-H3 in the successive stages of the prostate cancer, a tissue microarray (TMA) of clinically annotated human prostate (n  =  80) samples was analyzed. This evidence concerns the gene PTPN11 and prostate carcinoma.